Alain Decombe

Dechert advised Abivax, Reed Smith advised Claret Capital Partners and Reinhart Marville Torre accompanied Kreos Capital and Claret Capital Partners in their investment. Abivax announced structured debt...

Gide advised financial advisers SVB Securities, LifeSci Capital and Bryan and Garnier & Co. The banks were also advised by Cooley LLP on aspects of US...

Dechert advised Havea. PwC Société d’Avocats carried out tax due diligence on behalf of Havea Group. Havea Group has announced that it has entered into exclusive negotiations...

Dechert advised Cathay Capital on the deal. Clifford Chance advised Gland Pharma. Indian generic injectables maker Gland Pharma Ltd (GLAD.NS) announced it will buy privately held French...

Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...

Foley & Lardner LLP represented TCG Crossover on the deal while Dechert advised Abivax. TCG Crossover (TCGX) acted as the lead investor in the successful, oversubscribed EUR...

Paul, Weiss, Rifkind, Wharton & Garrison and Gide advised Apollo Global Management, while Dechert advised Sofinnova Partners in the deal. Apollo Global Management announced its strategic...

Deloitte | Taj et M&A Transaction Services and Dechert advised Mayoly Spindler, while Allen & Overy advised Ipsen. Weil Gotshal & Manges advised Caravelle and Capza...

The Paul Hastings team advised the shareholders of Carso, while Dechert advised ArchiMed on the deal. ArchiMed, a leading investment firm exclusively dedicated to the healthcare...

Dechert advised Ostium Group on the deal. Ostium Group, a medical deeptech specializing in innovative surgical instruments, completed its first fundraising led by Marle International Holding, Europe’s...

Dechert advised Abivax on the deal. Abivax, a Euronext Paris listed clinical-stage biotechnology company, executed its oversubscribed capital increase of €60 million and convertible bonds of...

Dechert and Villey Girard Grolleaud advised Affluent Medical on the deal. Affluent Medical, a French medtech company specialising in urology and cardiology, executed its IPO on the...